A Phase 1b Study of Combination of Avelumab and Taxane Based Chemotherapy in Platinum Refractory or Ineligible Metastatic Urothelial Cancer
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2019
Price : $35 *
At a glance
- Drugs Avelumab (Primary) ; Docetaxel (Primary)
- Indications Adenocarcinoma; Squamous cell cancer; Urogenital cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Oct 2018 Status changed from not yet recruiting to recruiting.
- 23 Sep 2018 Planned initiation date changed from 1 Aug 2018 to 1 Nov 2018.
- 05 Jul 2018 New trial record